AII
MRNA icon

AGF Investments Inc’s Moderna MRNA Stock Holding History

AGF Investments Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,826
Closed -$718K – 617
2021
Q4 		$718K Buy
2,826
+1,334
+89% +$390K 0.01% 457
2021
Q3 		$574K Sell
1,492
-4,352
-74% -$1.61M ﹤0.01% 471
2021
Q2 		$1.37M Buy
5,844
+283
+5% +$50.6K 0.01% 381
2021
Q1 		$728K Buy
5,561
+3,658
+192% +$530K 0.01% 452
2020
Q4 		$199K Sell
1,903
-707,444
-100% -$71.6M ﹤0.01% 599
2020
Q3 		$50.2M Buy
709,347
+217,880
+44% +$15.2M 0.5% 68
2020
Q2 		$31.6M Buy
+491,467
New +$26.9M 0.33% 103

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AGF Investments Inc's MRNA Position: Q1 2022 in Review

AGF Investments Inc sold out of Moderna (MRNA) in Q1 2022, closing a stake of 2,826 shares — an estimated $718K sold.

AGF Investments Inc first reported a position in MRNA in Q2 2020 and held it in 7 quarters. The position peaked at $50.2M in Q3 2020. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • AGF Investments Inc reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 2,826 Moderna shares in Q1 2022, an estimated $718K.
  • AGF Investments Inc first reported a position in Moderna in Q2 2020 and held it in 7 quarters.
  • AGF Investments Inc's Moderna position peaked at $50.2M in Q3 2020.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.